VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 151 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,791,805 | $64,992,000 | 3.92% |
Birchview Capital, LP | 80,000 | $1,371,000 | 0.93% |
Profit Investment Management, LLC | 78,154 | $1,339,000 | 0.93% |
Soleus Capital Management, L.P. | 298,600 | $5,118,000 | 0.80% |
GLOBEFLEX CAPITAL L P | 196,026 | $3,360,000 | 0.73% |
DENALI ADVISORS LLC | 89,300 | $1,531,000 | 0.64% |
ARMISTICE CAPITAL, LLC | 1,965,000 | $33,680,000 | 0.57% |
FinTrust Capital Advisors, LLC | 105,982 | $1,816,000 | 0.48% |
Zebra Capital Management LLC | 22,878 | $392,000 | 0.48% |
HUSSMAN STRATEGIC ADVISORS, INC. | 124,000 | $2,125,000 | 0.47% |